Durability of Class I American College of Cardiology/American Heart Association Clinical Practice Guideline Recommendations | Guidelines | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.64.36. Please contact the publisher to request reinstatement.
1.
Weisz  G, Cambrosio  A, Keating  P, Knaapen  L, Schlich  T, Tournay  VJ.  The emergence of clinical practice guidelines.  Milbank Q. 2007;85(4):691-727.PubMedGoogle ScholarCrossref
2.
Garber  AM.  Evidence-based guidelines as a foundation for performance incentives.  Health Aff (Millwood). 2005;24(1):174-179.PubMedGoogle ScholarCrossref
3.
Spertus  JA, Eagle  KA, Krumholz  HM, Mitchell  KR, Normand  SL; American College of Cardiology; American Heart Association Task Force on Performance Measures.  American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care.  Circulation. 2005;111(13):1703-1712.PubMedGoogle ScholarCrossref
4.
Shekelle  PG, Ortiz  E, Rhodes  S,  et al.  Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated?  JAMA. 2001;286(12):1461-1467.PubMedGoogle ScholarCrossref
5.
Ortiz  E, Eccles  M, Grimshaw  J, Woolf  S. Current Validity of AHRQ Clinical Practice Guidelines. US Agency for Healthcare Research and Quality. http://www.ncbi.nlm.nih.gov/books/NBK43864/. Accessed May 7, 2014.
6.
Lenzer  J.  Why we can’t trust clinical guidelines.  BMJ. 2013;346:f3830.PubMedGoogle ScholarCrossref
7.
Cabana  MD, Rand  CS, Powe  NR,  et al.  Why don’t physicians follow clinical practice guidelines? a framework for improvement.  JAMA. 1999;282(15):1458-1465.PubMedGoogle ScholarCrossref
8.
Pronovost  PJ.  Enhancing physicians’ use of clinical guidelines.  JAMA. 2013;310(23):2501-2502.PubMedGoogle ScholarCrossref
9.
Prasad  V, Cifu  A, Ioannidis  JP.  Reversals of established medical practices: evidence to abandon ship.  JAMA. 2012;307(1):37-38.PubMedGoogle ScholarCrossref
10.
Prasad  V, Gall  V, Cifu  A.  The frequency of medical reversal.  Arch Intern Med. 2011;171(18):1675-1676.PubMedGoogle ScholarCrossref
11.
Prasad  V, Vandross  A, Toomey  C,  et al.  A decade of reversal: an analysis of 146 contradicted medical practices.  Mayo Clin Proc. 2013;88(8):790-798.PubMedGoogle ScholarCrossref
12.
Institute of Medicine.  Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Press; 2011.
13.
Guyatt  GH, Oxman  AD, Vist  GE,  et al; GRADE Working Group.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.  BMJ. 2008;336(7650):924-926.PubMedGoogle ScholarCrossref
14.
Frye  RL, Collins  JJ, DeSanctis  RW,  et al.  Guidelines for permanent cardiac pacemaker implantation, May 1984: a report of the Joint American College of Cardiology/American Heart Association Task Force on Assessment of Cardiovascular Procedures (Subcommittee on Pacemaker Implantation).  Circulation. 1984;70(2):331A-339A.PubMedGoogle Scholar
15.
Ryan  TJ, Anderson  JL, Antman  EM,  et al.  ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).  J Am Coll Cardiol. 1996;28(5):1328-1428.PubMedGoogle ScholarCrossref
16.
Eagle  KA, Guyton  RA, Davidoff  R,  et al.  ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).  Circulation. 2004;110(14):e340-e437.PubMedGoogle Scholar
17.
Tricoci  P, Allen  JM, Kramer  JM, Califf  RM, Smith  SC  Jr.  Scientific evidence underlying the ACC/AHA clinical practice guidelines.  JAMA. 2009;301(8):831-841.PubMedGoogle ScholarCrossref
18.
Fuster  V, Rydén  LE, Asinger  RW,  et al.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.  Eur Heart J. 2001;22(20):1852-1923.PubMedGoogle ScholarCrossref
19.
Fuster  V, Rydén  LE, Cannom  DS,  et al.  ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.  Circulation. 2006;114(7):e257-e354.PubMedGoogle ScholarCrossref
20.
Eagle  KA, Berger  PB, Calkins  H,  et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). http://www.uthsc.edu/Internal/syllabus-consult/complete%20AHA%20guidelines.pdf. Accessed November 12, 2013.
21.
Fleisher  LA, Beckman  JA, Brown  KA,  et al.  ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.  Circulation. 2007;116(17):e418-e499.PubMedGoogle ScholarCrossref
22.
Epstein  AE, DiMarco  JP, Ellenbogen  KA,  et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.  Circulation. 2008;117(21):e350-e408.PubMedGoogle ScholarCrossref
23.
Gregoratos  G, Abrams  J, Freedman  RA,  et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Pacemaker Implantation). http://www.cardiosource.com/guidelines/guidelines/pacemaker/Pacemakerclean.pdf. Accessed November 12, 2013.
24.
Smith  SC  Jr, Allen  J, Blair  SN,  et al; AHA/ACC; National Heart, Lung, and Blood Institute.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.  Circulation. 2006;113(19):2363-2372.PubMedGoogle ScholarCrossref
25.
Smith  SC  Jr, Benjamin  EJ, Bonow  RO,  et al; World Heart Federation and the Preventive Cardiovascular Nurses Association.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.  Circulation. 2011;124(22):2458-2473.PubMedGoogle ScholarCrossref
26.
Hillis  LD, Smith  PK, Anderson  JL,  et al.  2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.  Circulation. 2011;124(23):e652-e735.PubMedGoogle ScholarCrossref
27.
Mosca  L, Banka  CL, Benjamin  EJ,  et al; Expert Panel/Writing Group; American Heart Association; American Academy of Family Physicians; American College of Obstetricians and Gynecologists; American College of Cardiology Foundation; Society of Thoracic Surgeons; American Medical Women’s Association; Centers for Disease Control and Prevention; Office of Research on Women’s Health; Association of Black Cardiologists; American College of Physicians; World Heart Federation; National Heart, Lung, and Blood Institute; American College of Nurse Practitioners.  Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.  Circulation. 2007;115(11):1481-1501.PubMedGoogle ScholarCrossref
28.
Mosca  L, Benjamin  EJ, Berra  K,  et al.  Effectiveness-based guidelines for the prevention of cardiovascular disease in women: 2011 update: a guideline from the American Heart Association.  Circulation. 2011;123(11):1243-1262.PubMedGoogle ScholarCrossref
29.
Hunt  SA, Abraham  WT, Chin  MH,  et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.  Circulation. 2005;112(12):e154-e235.PubMedGoogle ScholarCrossref
30.
Yancy  CW, Jessup  M, Bozkurt  B,  et al; Writing Committee Members.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.  Circulation. 2013;128(16):e240-e327.PubMedGoogle ScholarCrossref
31.
Levine  GN, Bates  ER, Blankenship  JC,  et al.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions [published correction appears in Circulation. 2012;125(8):e412].  Circulation. 2011;124(23):e574-e651.PubMedGoogle ScholarCrossref
32.
Smith  SC  Jr, Feldman  TE, Hirshfeld  JW  Jr,  et al.  ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).  Circulation. 2006;113(7):e166-e286.PubMedGoogle ScholarCrossref
33.
Fihn  SD, Gardin  JM, Abrams  J,  et al.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.  Circulation. 2012;126(25):e354-e471.PubMedGoogle ScholarCrossref
34.
Gibbons  RJ, Abrams  J, Chatterjee  K,  et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). http://www.cardiosource.org/~/media/Images/ACC/Science%20and%20Quality/Practice%20Guidelines/s/stable_clean.ashx. Accessed November 12, 2013.
35.
Anderson  JL, Adams  CD, Antman  EM,  et al.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.  Circulation. 2007;116(7):e148-e304.PubMedGoogle ScholarCrossref
36.
Braunwald  E, Antman  EM, Beasley  JW,  et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). http://www.uthsc.edu/cardiology/articles/2002%20UA_NSTEMI.pdf. Accessed November 12, 2013.
37.
Bonow  RO, Carabello  B, de Leon  AC  Jr,  et al.  Guidelines for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).  Circulation. 1998;98(18):1949-1984.PubMedGoogle ScholarCrossref
38.
Bonow  RO, Carabello  BA, Kanu  C,  et al.  ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.  Circulation. 2006;114(5):e84-e231.PubMedGoogle ScholarCrossref
39.
Antman  EM, Anbe  DT, Armstrong  PW,  et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).  Circulation. 2004;110(9):e82-e292.PubMedGoogle Scholar
40.
O’Gara  PT, Kushner  FG, Ascheim  DD,  et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.  Circulation. 2013;127(4):e362-e425.PubMedGoogle ScholarCrossref
41.
Fleisher  LA, Beckman  JA, Brown  KA,  et al.  ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology.  Circulation. 2006;113(22):2662-2674.PubMedGoogle ScholarCrossref
42.
US Preventive Services Task Force Procedure Manual: section 2: topic selection, prioritization, and updating. US Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf08/methods/procmanual2.htm. Accessed April 2, 2014.
Original Investigation
May 28, 2014

Durability of Class I American College of Cardiology/American Heart Association Clinical Practice Guideline Recommendations

Author Affiliations
  • 1Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • 2Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia
  • 3Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • 4Department of Health Care Management, Wharton School of Business, University of Pennsylvania, Philadelphia
JAMA. 2014;311(20):2092-2100. doi:10.1001/jama.2014.4949
Abstract

Importance  Little is known regarding the durability of clinical practice guideline recommendations over time.

Objective  To characterize variations in the durability of class I (“procedure/treatment should be performed/administered”) American College of Cardiology/American Heart Association (ACC/AHA) guideline recommendations.

Design, Setting, and Participants  Textual analysis by 4 independent reviewers of 11 guidelines published between 1998 and 2007 and revised between 2006 and 2013.

Main Outcomes and Measures  We abstracted all class I recommendations from the first of the 2 most recent versions of each guideline and identified corresponding recommendations in the subsequent version. We classified recommendations replaced by less determinate or contrary recommendations as having been downgraded or reversed; we classified recommendations for which no corresponding item could be identified as having been omitted. We tested for differences in the durability of recommendations according to guideline topic and underlying level of evidence using bivariable hypothesis tests and conditional logistic regression.

Results  Of 619 index recommendations, 495 (80.0%; 95% CI, 76.6%-83.1%) were retained in the subsequent guideline version, 57 (9.2%; 95% CI, 7.0%-11.8%) were downgraded or reversed, and 67 (10.8%; 95% CI, 8.4%-13.3%) were omitted. The percentage of recommendations retained varied across guidelines from 15.4% (95% CI, 1.9%-45.4%) to 94.1% (95% CI, 80.3%-99.3%; P < .001). Among recommendations with available information on level of evidence, 90.5% (95% CI, 83.2%-95.3%) of recommendations supported by multiple randomized studies were retained, vs 81.0% (95% CI, 74.8%-86.3%) of recommendations supported by 1 randomized trial or observational data and 73.7% (95% CI, 65.8%-80.5%) of recommendations supported by opinion (P = .001). After accounting for guideline-level factors, the probability of being downgraded, reversed, or omitted was greater for recommendations based on opinion (odds ratio, 3.14; 95% CI, 1.69-5.85; P < .001) or on 1 trial or observational data (odds ratio, 3.49; 95% CI, 1.45-8.41; P = .005) vs recommendations based on multiple trials.

Conclusions and Relevance  The durability of class I cardiology guideline recommendations for procedures and treatments promulgated by the ACC/AHA varied across individual guidelines and levels of evidence. Downgrades, reversals, and omissions were most common among recommendations not supported by multiple randomized studies.

×